ResMed, ATS partner on NIV grant

 - 
Thursday, April 6, 2017

SAN DIEGO – ResMed has funded a new $100,000 two-year grant with the American Thoracic Society to research non-invasive ventilation for COPD patients. COPD affects 65 million people worldwide and is the third leading cause of death, according to a press release. “Through this award, the field of respiratory medicine stands to gain more valuable knowledge about the use of NIV for the treatment of COPD with the ultimate goal of improving the lives of patients and the efficiency of our health care system as a whole,” said Carlos Nunez, MD, chief medical officer for ResMed.